 |
|
 |
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
2 Baylor College of Medicine, Houston, Texas
3 The University of Southern California School of Medicine, Los Angeles, California
4 Northwestern University Medical School, Chicago, Illinois
5 The George Washington University School of Medicine and Health Sciences, Washington, DC
6 Ohio State University College of Medicine, Columbus, Ohio
Objective. To determine whether treatment with dexamethasone and ceftriaxone for children with bacterial meningitis reduces the frequency of either sensorineural hearing loss or other neurologic sequelae.
Design. This was a prospective, multicentered, placebo-controlled clinical trial. Subjects were followed for 1 year.
Setting. The study was conducted in six children's hospitals located in Pittsburgh, Houston, Los Angeles, Chicago, Washington, D.C., and Columbus, Ohio.
Patients. Enrolled were 173 children, 8 weeks to 12 years of age, with suspected bacterial meningitis; 143 children were evaluable. Eighty-seven percent of patients were followed for at least 6 weeks to 3 months, and 67% were followed for 1 year.
Interventions. Subjects were randomized to receive ceftriaxone with or without dexamethasone (0.15 mg/kg every 6 hours for 4 days). Auditory brainstem responses (ABR) were measured within 24 hours of admission.
Main outcome measures. Hearing, development, and neurologic sequelae were assessed at the time of discharge and 6 weeks and 1 year later.
Main results. One hundred forty-three patients (69 received dexamethasone and 74 received placebo) with bacterial meningitis were evaluable: Haemophilus influenzae type b (83), Streptococcus pneumoniae (33), Neisseria meningitidis (24), and three others. Overall, there was no significant difference in auditory outcome between dexamethasone and placebo recipients. Twenty-two children had bilateral moderate or more severe hearing loss at the time of the first ABR. At follow-up, the resolution of hearing impairment was nearly identical for each group. Nine of ten children who remained persistently deaf were deaf at the time of the first ABR. There were no differences in neurologic or developmental outcome between groups.
Conclusion. All but one child with persistent bilateral moderate or more severe hearing loss had demonstrable deafness at the time of the first ABR. Dexamethasone did not significantly improve audiologic, neurologic, or developmental outcome in children with bacterial meningitis.
Submitted on December 13, 1993
This article has been cited by other articles:
 |
|
 |
|
  S. McGee and J. Hirschmann Use of Corticosteroids in Treating Infectious Diseases Arch Intern Med, May 26, 2008; 168(10): 1034 - 1046. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S I Pelton and R Yogev Improving the outcome of pneumococcal meningitis Arch. Dis. Child., April 1, 2005; 90(4): 333 - 334. [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Nigrovic, N. Kuppermann, and R. Malley Development and Validation of a Multivariable Predictive Model to Distinguish Bacterial From Aseptic Meningitis in Children in the Post-Haemophilus influenzae Era Pediatrics, October 1, 2002; 110(4): 712 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Dodge, M. Scaer, S. J. Holmes, S. L. Pomeroy, and R. D. Feigin Psychometric Testing in Bacterial Meningitis: Results of a Long-Term Prospective Study of Infants and Children Treated Between 1973 and 1977 J Child Neurol, January 1, 2001; 16(11): 854 - 857. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Peltola Worldwide Haemophilus influenzae Type b Disease at the Beginning of the 21st Century: Global Analysis of the Disease Burden 25 Years after the Use of the Polysaccharide Vaccine and a Decade after the Advent of Conjugates Clin. Microbiol. Rev., April 1, 2000; 13(2): 302 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. van Deuren, P. Brandtzaeg, and J. W. M. van der Meer Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management Clin. Microbiol. Rev., January 1, 2000; 13(1): 144 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Richardson, T. J. Williamson, A. Reid, M. J. Tarlow, and P. T. Rudd Otoacoustic Emissions as a Screening Test for Hearing Impairment in Children Recovering From Acute Bacterial Meningitis Pediatrics, December 1, 1998; 102(6): 1364 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Arditi, E. O. Mason Jr, J. S. Bradley, T. Q. Tan, W. J. Barson, G. E. Schutze, E. R. Wald, L. B. Givner, K. S. Kim, R. Yogev, et al. Three-Year Multicenter Surveillance of Pneumococcal Meningitis in Children: Clinical Characteristics, and Outcome Related to Penicillin Susceptibility and Dexamethasone Use Pediatrics, November 1, 1998; 102(5): 1087 - 1097. [Abstract] [Full Text]
|
|
|
|
|
|
S. L. Kaplan and E. O. Mason Jr. Management of Infections Due to Antibiotic-Resistant Streptococcus pneumoniae Clin. Microbiol. Rev., October 1, 1998; 11(4): 628 - 644. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. J. Quagliarello and W. M. Scheld Treatment of Bacterial Meningitis N. Engl. J. Med., March 6, 1997; 336(10): 708 - 716. [Full Text] [PDF]
|
|
|
|
|
|
M P Richardson, A Reid, M J Tarlow, and P T Rudd Hearing loss during bacterial meningitis Arch. Dis. Child., February 1, 1997; 76(2): 134 - 138. [Abstract] [Full Text]
|
|
|
|
 |
|
 DEXAMETHASONE THERAPY FOR CHILDHOOD BACTERIAL MENINGITIS QUESTIONED Journal Watch (General), January 17, 1995; 1995(117): 3 - 3. [Full Text]
|
|
 |
||
|
||
Home | My Pediatrics | Journal Information | Current Issue | Past Issues | Subscriptions & Services | Contact Us Click here for faster international access © 1995 American Academy of Pediatrics. All rights reserved. |
||
|
||
